What
Where
Preclinical Research & Development
(Expired)From: MerX(Federal)
 Basic Details |  Start Date15 Dec, 2023 (4 months ago) Due Date05 Jan, 2024 (3 months ago) TypeBid NotificationIdentifierPreclinical Research & Development | ||||
 Customer / Agency | Canadian Nuclear Laboratories Ltd. (CNL) | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
Preclinical Research & Development Project Description :The Proponent will provide services as a test site for Good Laboratory Practices (GLP) regulatory studies, Canadian Nuclear Laboratories Ltd (CNL) will be the test facility. Some or all of the following services are requested: - Histopathology - Ophthalmology - Toxicology review of
Location
Address: MERX 6 Antares Dr, Phase II unit 103 Ottawa, ON K2E 8A9
Country : CanadaYou may also like
PREVENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS; TASK ORDER TITLE: PRECLINICAL DEVELOPMENT OF AN RNA VACCINE FOR IMMUNOPREVENTION OF ...
Due: 07 Jan, 2025 (in 8 months)NIDA DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER MANAGEMENT AND SUPPORT. 07/01/2021 - 6/14/2024. N01DA-19-2250. TASK ORDER 75N95021F00004 (TO23).
Due: 14 Jun, 2024 (in 1 month)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.